Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

Clinical trial NCT02636036 · COMPLETED

Trial details

NCT number: NCT02636036
Sponsor: Akamis Bio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Squamous Cell Carcinoma of the Head and Neck Epithelial Tumor

Start date: 2016-01-25
Primary completion: 2021-10-08
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.